T24 [T-24](人膀胱移行细胞癌细胞)

https://789.bio/ec/p900R0
  • https://789.bio/ec/p900R0
  • https://789.bio/ec/RCGZm1
  • https://789.bio/ec/LZD8d5
  • https://789.bio/ec/iWi5dD
  • https://789.bio/ec/VuLC48
  • https://789.bio/ec/CGGtmH
  • https://789.bio/ec/tD4xm5

货号: CL-0227

Price: ¥1600 ¥1600

Size:
1×10^6Cells/T25 1×10^6Cells/Vial×2Vials

生长培养基: McCoy's 5A[PM150710]+10% FBS[164210]+1% P/S[PB180120]

产品信息

产品名称 T24 [T-24](人膀胱移行细胞癌细胞)
别称 T-24; T 24
生长特性 贴壁细胞
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40% FBS+5% DMSO
温度:液氮
培养方案A(默认) 生长培养基:McCoy's 5A[PM150710]+10% FBS[164210]+1% P/S[PB180120]
培养条件: 气相:空气,95%;CO₂,5%, 温度:37℃
培养方案B(可选) 生长培养基:
培养条件: 气相:, 温度:37℃
推荐传代比例 1:2-1:4
推荐换液频率 2-3次/周

参考资料(来源文献)

背景描述 T24细胞源自病人的转移性细胞腺癌,对T24和相关细胞株有细胞毒性。T24细胞群体倍增时间为19小时,含ras (H-ras)癌基因。
年龄(性别) 81Y Female
组织来源 膀胱;移行细胞癌
细胞类型 肿瘤细胞
肿瘤类型 膀胱癌细胞
生物安全等级 BSL-1
致瘤性 Yes, in hamster cheek pouch.No, in nude mice.

STR位点信息

STR鉴定图

  • TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistance(2025)

    作者:Zhi Liu, Chunyu Zhang, Jiatong Xiao, Yunbo He, Haisu Liang, Jinliang Huang, Zhiyong Cai, Zhenglin Yi, Mingfeng Chen, Yixiao Li, Jun Zhang, Fenglian liu, Peng Ren, Huihuang Li, Jinbo Chen, Benyi Fan, Jiao Hu, Xiongbing Zu, Dingshan Deng

    期刊:Theranostics

    DOI:10.7150/thno.103175

    影响因子:12.4

    引用产品: T24 [T-24] 细胞, TCCSUP 细胞

  • The combination treatment of RC48 and STAT3 inhibitor acts as a promising therapeutic strategy for basal bladder cancer(2025)

    作者:Jingxian Li, Kun Shan, Wei Huang, Qiang Su, Yuanjiong Qi, Zhihong Zhang, Jianqiang Zhu, E. Du

    期刊:Frontiers in Immunology

    DOI:10.3389/fimmu.2024.1432586

    影响因子:5.7

    引用产品: SW 780 [SW-780, SW780] 细胞, HT-1376 细胞, RT4 细胞, 5637 细胞, T24 [T-24] 细胞, J82 细胞

  • Suppressing the progression of bladder cancer using cyclovirobuxine D based on network pharmacology and bioinformatics approaches(2025)

    作者:Gao Ke, Jiang Hanbing, Zhang Chao, Li Lin, Qi Yuhong, Yang Nan, Li Xiaoshun, Wang Yongshun, Wu Bin, Shao Qiuju, Wu Guojun

    期刊:NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

    DOI:10.1007/s00210-024-03754-9

    影响因子:3.1

    引用产品: UM-UC-3 细胞, T24 [T-24] 细胞

  • Construction and validation of prognosis and treatment outcome models based on plasma membrane tension characteristics in bladder cancer(2025)

    作者:Zhipeng Wang, Sheng Li, Fuchun Zheng, Situ Xiong, Lei Zhang, Liangwei Wan, Chen Wang, Xiaoqiang Liu, Jun Deng

    期刊:PeerJ

    DOI:10.7717/peerj.18816

    影响因子:2.3

    引用产品: BIU-87 细胞, T24 [T-24] 细胞

  • Orchestrated desaturation reprogramming from stearoyl-CoA desaturase to fatty acid desaturase 2 in cancer epithelial-mesenchymal transition and metastasis(2024)

    作者:Zhicong Chen, Yanqing Gong, Fukai Chen, Hyeon Jeong Lee, Jinqin Qian, Jing Zhao, Wenpeng Zhang, Yamin Li, Yihui Zhou, Qiaobing Xu, Yu Xia, Liqun Zhou, Ji-Xin Cheng

    期刊:Cancer Communications

    DOI:10.1002/cac2.12644

    影响因子:20.1

    引用产品: T24 [T-24] 细胞, SW 780 [SW-780, SW780] 细胞, MDA-MB-231 细胞, MCF7 [MCF-7] 细胞, PANC-1 细胞, BxPC-3 细胞, 293T [HEK-293T] 细胞

  • Harnessing Natural Pollen as Sustained-Release, Mucoadhesive, and Biosafe Drug Microcapsules for Intravesical Instillation in Bladder Cancer Treatment(2024)

    作者:Weimin Hu, Zhixuan Zhou, Fan Zou, Yaoqiu Huang, Ming Li, Yunlong Zhang, Kefang Sun, Hongbing Deng, Fan Cheng, Ze Zhao, Weimin Yu

    期刊:Small

    DOI:10.1002/smll.202406351

    影响因子:13.0

    引用产品: T24 [T-24] 细胞, MB49 细胞, SV-HUC-1 细胞

  • Mechanistic insights into SIRT7 and EZH2 regulation of cisplatin resistance in bladder cancer cells(2024)

    作者:Cao Yudong, Wang Shuo, Ma Jinchao, Long Mengping, Ma Xiuli, Yang Xiao, Ji Yongpeng, Tang Xingxing, Liu Jia, Lin Chen, Yang Yong, Du Peng

    期刊:Cell Death & Disease

    DOI:10.1038/s41419-024-07321-1

    影响因子:8.1

    引用产品: SV-HUC-1 细胞, T24 [T-24] 细胞, UM-UC-3 细胞, J82 细胞, TCCSUP 细胞, SW 780 [SW-780, SW780] 细胞, RT-112 细胞, 特级胎牛血清, 青霉素-链霉素溶液(双抗),100×, Ham's F-12K 培养基, McCoy's 5A 培养基, MEM(含NEAA) 培养基, Leibovitz's L-15 培养基, RPMI-1640 培养基

  • A comprehensive analysis-based study of Di-(2-ethylhexyl) phthalate (DEHP)—Environmental explanation of bladder cancer progression(2024)

    作者:Fei Lin, Wen-Cai Zheng, Zhi-Bin Ke, Dong-Ning Chen, Yu-Ting Xue, Yun-Zhi Lin, Xiao-Dong Li, Qing-Shui Zheng, Yong Wei, Xue-Yi Xue, Ning Xu

    期刊:ENVIRONMENTAL POLLUTION

    DOI:10.1016/j.envpol.2024.125625

    影响因子:7.6

    引用产品: 5637 细胞, T24 [T-24] 细胞

  • Nuclear translocation of ISG15 regulated by PPP2R2B inhibits cisplatin resistance of bladder cancer(2024)

    作者:Huang Gaowei, Liu Jinwen, Yu Anze, Luo Chenggong, Zhu Jiangquan, Wang Yinghan, Dai Ziran, Zhang Lizhen, Feng Zihao, Lu Jun, Dong Zhong, Luo Junhang, Chen Wei, Chen Zhenhua

    期刊:CELLULAR AND MOLECULAR LIFE SCIENCES

    DOI:10.1007/s00018-024-05320-1

    影响因子:6.2

    引用产品: J82 细胞, 5637 细胞, T24 [T-24] 细胞, UM-UC-3 细胞, SV-HUC-1 细胞

  • Exploration and validation of a novel reactive oxygen species–related signature for predicting the prognosis and chemotherapy response of patients with bladder cancer(2024)

    作者:Yulei Li, Lulu Zhang, Gang Xu, Gang Xu, Jiajun Chen, Keyuan Zhao, Mengyao Li, Jing Jin, Chao Peng, Kaifang Wang, Shouhua Pan, Ke Zhu

    期刊:Frontiers in Immunology

    DOI:10.3389/fimmu.2024.1493528

    影响因子:5.7

    引用产品: T24 [T-24] 细胞, 5637 细胞

  • Q1:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢?

    部分细胞是会出现多种培养条件的,我们公司优先选择引种来源的培养条件以及建系者所用培养条件,出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件,为了避免细胞突然更换培养条件后不适应,建议您优先使用厂家推荐的培养条件培养。

识别码示意图

联系我们

400-999-2100

24小时服务热线

sales@procell.com.cn

销售邮箱

×
微信客服 联系我们 返回顶部
在线咨询